The price of a drug should be based on its therapeutic benefits – not just what the market will bear
- Written by Nicole Hassoun, Professor of Philosophy, Binghamton University, State University of New York
The average price for an orphan drug is more than $150,000 per year.GP Kidd/Cultura/Getty ImagesThe U.S. pharmaceutical industry has innovated in response to the pandemic, providing not only vaccines but also therapies to treat people with COVID-19. But an outdated law designed to spur development of lifesaving drugs risks making new treatments...
